ArticleCell death & disease2022

Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition.

Bao-Dong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.